Pharma Consulting Plays A Key Role In Leveraging Pharmaceutical Sales

The healthcare system represents an extremely complex dynamic and due to its size can be a primary driver of a country's economic engine. There are many different incentives and restrictions governing the use of an individual pharmaceutical product and many different agendas along the way. Before a pharmaceutical products can be brought to the market, it faces a difficult road from the desk of a scientist to the hand of the consumer. Invariably, pharmaceutical consultants are critical to this journey, as they help all those involved to understand the situation, disseminate the information and make decisions.

A pharmaceutical company faces many challenges, quite apart from the manufacture of its products. The pharmaceutical consulting firm helps the company understand how it needs to educate the consumer. Pharmaceutical companies regularly operate on the sharp end of discovery and their revelations may be truly ground-breaking. Without an adequate marketing channel, these findings might never make their way via the regulators to the front-line professionals. Marketing also insists that the product features and benefits are correctly communicated to the financiers, principally the insurance companies, who seem to have an ever-increasing role in the dissemination of care.

While regulators will ultimately determine if a pharmaceutical product may be made available and will confirm the associated claims, the pharmaceutical company must be able to market itself, its reputation and its products within the ultra-competitive and distracted healthcare industry. It should be noted that certain principals within the industry have an incentive to steer healthcare practitioners and their patients toward older, or generic medications and that these agendas may not be in the best interests of the sufferer. Pharmaceutical companies have a clear incentive to trumpet the benefits of their wares in such a noisy marketplace and help to create a dynamic and forward thinking mindset.

It is unfortunate that the ultimate care of the patient is very often not the ultimate goal of certain vested interests. While healthcare reform and especially its associated finances remain a hot button issue, the pharmaceutical company must do everything in its power to ensure that its lines of communication are open. The physician takes input from many different sources before he or she makes the decision as to final care, including experience, peer input, education and training, patient history, formularies, techniques and benchmarks - all play their role. Statistics tell us that 90% of the most frequently prescribed drugs are generics and thus it is difficult for pharmaceutical companies to ensure that they are being heard in the right place at the right time. In most cases, pharma consulting firms are used to this difficult environment and can certainly help to open channels and engage practices.

Pharmaceutical companies have been responsible for many of the most amazing discoveries in the world of medicine. Previous generations would surely marvel at some of the cures available today. To enable healthcare to continue to get better, much emphasis must be placed on marketing.

Alan Gillies is the Managing Director of L2L Consulting, specialising in enabling pharmaceutical companies to achieve new heights of productivity and performance, throughout all levels of management and revenue generating activities.